General Medicine and Primary Care

Episodes 1-16 of 87

Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Global Oncology Academy
Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
- Gerard A. Silvestri MD, MS, Master FCCP
- Jessica S. Donington, MD, MSCR
- Mariam Alexander, MD, PhD
- Anurag Singh, MD
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Global Oncology Academy
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
- Gerard A. Silvestri MD, MS, Master FCCP
- Jessica S. Donington, MD, MSCR
- Mariam Alexander, MD, PhD
- Anurag Singh, MD
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Project Oncology®
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
- Ryan Quigley
Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening
Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening
Project Oncology®
Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening
- Brian P. McDonough, MD, FAAFP
- Mylynda Massart, MD, PhD
Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
Project Oncology®
Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
- Brian P. McDonough, MD, FAAFP
- Marie Wood, MD
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Clinician's Roundtable
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
- Aasma Shaukat, MD, MPH
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
- Ryan Quigley
- Hallie Blevins, PhD.
- Marlene Mimi Maeusli, PhD.
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Project Oncology®
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
- Marlene Mimi Maeusli, PhD.
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Project Oncology®
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
- Ryan Quigley
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Clinician's Roundtable
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
- Pedro Nascimento de Lima, PhD
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
- Ryan Quigley
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Clinician's Roundtable
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
- Charles Turck, PharmD, BCPS, BCCCP
- Gloria Coronado, PhD
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
Global Oncology Academy
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
- Wayne Kuang, MD
- William Oh, MD
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
Global Oncology Academy
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
- William Oh, MD
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
Global Oncology Academy
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
- Lisa Newcomb, PhD
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Global Oncology Academy
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
- Lisa Newcomb, PhD